(Q44332717)

2 December 2017

title

Decreased opioid-induced antinociception but unaltered G-protein activation in the genetic-diabetic NOD mouse (English)

1 reference

2 December 2017

Pieper GM

1

1 reference

2 December 2017

Mizoguchi H

2

1 reference

2 December 2017

Ohsawa M

3

1 reference

2 December 2017

Kamei J

4

1 reference

2 December 2017

Nagase H

5

1 reference

2 December 2017

Tseng LF

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

European Journal of Pharmacology

2 December 2017

published in

1 reference

2 December 2017

volume

401

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

375-379

1 reference

Diabetes-induced alterations in the expression, functioning and phosphorylation state of the inhibitory guanine nucleotide regulatory protein Gi-2 in hepatocytes

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900459-3

Opiate-mediated inhibition of calcium signaling is decreased in dorsal root ganglion neurons from the diabetic BB/W rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900459-3

Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ- and κ-opioid agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900459-3

Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900459-3

Effect of diabetes on the antinociceptive effect of beta-endorphin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900459-3

Modulation by serum glucose levels on morphine-induced antinociceptive effect in C57BL/KsJ-db/db mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900459-3

Activation of G-proteins in the mouse pons/medulla by beta-endorphin is mediated by the stimulation of mu- and putative epsilon-receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900459-3

Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900459-3

Heroin antinociception changed from mu to delta receptor in streptozotocin-treated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900459-3

Antinociceptive effects of morphine were different between experimental and genetic diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900459-3

Region-dependent G-protein activation by mu-, delta 1- and delta 2-opioid receptor agonists in the brain: comparison between the midbrain and forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900459-3

Activation of a NO-cyclic GMP system by NO donors potentiates beta-endorphin-induced antinociception in the mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900459-3

10.1016/S0014-2999(00)00459-3

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference